Facebook
X
LinkedIn
ForwardSpasticity and Movement Disorders IMPACT Initiative (IMproving Patient Assessment and Chemodenervation Treatment
Improve your ability to identify muscle groups, explore treatment for spasticity and movement disorders, engage in multidisciplinary care, and participate in hands-on opportunities with two unique, profession-specific tracks.
Target Audience
The initiative is intended for neurologists, physiatrists, orthopedic surgeons, nurse practitioners, physician assistants, nurses and physical and occupational therapists.
Learning Objectives
MD Track
- Describe the clinical presentation, diagnosis, and treatment of patients with cervical dystonia, limb dystonias, and spasticity
- Review the mechanism of action, indications, and clinical application of botulinum neurotoxin (BoNT) herapy in patients with cervical dystonia, limb dystonias, and spasticity
- Identify the indications and unique dosing requirements of the current BoNTs for the treatment of cervical dystonia, limb dystonias, and spasticity
- Demonstrate guidance techniques for the safe and effective injection of BoNT in patients with cervical dystonia, limb dystonias, and spasticity
- Identify sonoacoustic anatomical features of cervical and limb muscles, nerves, and other structures using ultrasound guidance to improve the safety and accuracy of BoNT injections
- Develop strategies for individualizing therapy and assisting patients with cervical dystonia, limb dystonias, and spasticity in achieving their functional goals
PT/OT Track
- Recognize common patterns of muscle overactivity (MoA) that occur in patients with upper motor neuron syndrome and dystonia
- Identify when patients with MoA should be referred for treatment (problematic MoA)
- Recognize the importance of patient evaluation, collaborative care, and setting patient-specific goals on treatment outcomes
- Demonstrate appropriate manual therapy, splinting, and casting techniques to enhance patient selection for and maximize functional outcomes in the post chemodenervation setting
- Integrate strategies to individualize functional goals considering varying types of patient scenarios
- Review the potential utility of ultrasound in management of upper and lower limb dystonias
Commercial Support
This activity is supported by an educational grant and in-kind support from AbbVie Inc., Ipsen Biopharmaceuticals, and Merz.
This activity is supported by in-kind support contributions from AbbVie Inc., Ipsen Biopharmaceuticals, and Merz
Course summary
- 8.00 AAPA Category 1 CME
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. - 8.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 8.00 ANCC Contact Hours
Nurses
Credit being awarded: 8.00 ANCC contact hours - 8.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
Katharine Alter, MD
Dorothy Caputo, MA BSN RN
Bahroo Laxman, DO, FAAN, FANA
Dorothy Caputo, MA BSN RN
Rebecca Lakofsky, BSN, RN
Katharine Alter, MD
Cindy Ivanhoe, MD
Barbara Karp, MD
Bahroo Laxman, DO, FAAN, FANA
Stephen Nichols, MD, FAAP, FAAPMR
Sharon Selko, PT, C/NDT
David Simpson, MD, FAAN
Laura Wiggs, PT, NCS, CBIS
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 8 Interprofessional Continuing Education (IPCE) credit for learning and change.
Available Credit
- 8.00 AAPA Category 1 CME
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. - 8.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 8.00 ANCC Contact Hours
Nurses
Credit being awarded: 8.00 ANCC contact hours - 8.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.